Mar. 21, 2006 – BioForce Nanosciences Holdings Inc. (OTC.BB: BFNH) today announced that it has closed a $6 million private placement of restricted common shares at $1.50 a share.
BioForce’s core technology is the NanoArrayer System, a proprietary instrumentation and software tool for the life sciences. The Ames, Iowa-based company is also commercializing a patented diagnostic device called the ViriChip System, which is used for detection and identification of multiple viruses and other pathogens simultaneously on a single chip.